Page 93 - e-CPG-SLE-8_5_24
P. 93

Management of Systemic Lupus Erythematosus

                            LIST OF ABBREVIATIONS

            24hUP       24-hour urine protein
            aCL         anticardiolipin antibodies
            ACR         American College of Rheumatology
            AE          adverse event
            AGREE       Appraisal of Guidelines for Research and Evaluation
            AIHA        autoimmune haemolytic anaemia
            ALMS        Aspreva Lupus Management Study
            ALP         alkaline phosphatase
            ANA         antinuclear antibodies
            anti-β2GP1   anti-beta-2-glycoprotein 1
            anti-dsDNA   anti-double stranded deoxyribonucleic acid
            anti-RNP    antibodies to ribonucleoprotein
            anti-Sm     anti-Smith
            anti-SSA    anti-Sjögren’s-syndrome-related antigen A
            anti-SSB    anti-Sjögren’s-syndrome-related antigen B
            aPL         antiphospholipid antibodies
            APS         antiphospholipid syndrome
            ARA         American Rheumatism Association
            AZA         azathioprine
            BAFF        B-cell activating factor
            BD          bis in die (twice a daily)
            BICLA       British Isles Lupus Assessment Group-based Composite Lupus
                        Assessment
            BILAG       British Isles Lupus Activity Group
            BLISS       Belimumab in Subjects with Systemic Lupus Erythematosus
            BLyS        B-lymphocyte stimulator
            BMD         bone mineral density
            BMI         body-mass index
            BSR         British Society for Rheumatology
            C3          complement 3
            C4          complement 4
            CI          confidence interval
            CLASI       Cutaneous Lupus Erythematosus Disease Area and Severity Index
            CLE         cutaneous lupus erythematosus
            CNI         calcineurin inhibitors
            COX-2       cyclooxygenase-2
            CPG         clinical practice guidelines
            CrCl        creatinine clearance
            CRP         C-reactive protein
            CT          computed tomography
            CYC         cyclophosphamide
            CV          cardiovascular
            CVD         cardiovascular disease
            DG          development group
            DMPA        depot medroxyprogesterone acetate
            DOAC        direct oral anticoagulant
            DORIS       Definition of Remission in SLE
            DNA         deoxyribonucleic acid
            ECG         electrocardiogram
            eGFR        estimated glomerular filtration rate

                                      76
   88   89   90   91   92   93   94   95   96   97   98